CIENCIASMEDICASNEWS: Studying the Proteome and Human Diseases using Mass Spectrometry

sábado, 19 de septiembre de 2020

Studying the Proteome and Human Diseases using Mass Spectrometry

	Microbiology
	The latest microbiology news from AZoNetwork

New study will "fundamentally change the way researchers study the microbiome"

Studying the Proteome and Human Diseases using Mass Spectrometry

It is incredibly important to study the proteome to understand human diseases. There are two different ways in which looking at the proteome can be advantageous: the first is looking at diagnostics, and the second is understanding treatment options.

For example, if you have a patient who is developing a disease, often that disease will be triggered by the expression of proteins that either would not be present in the healthy state or potentially would be present in different amounts in a healthy state versus a diseased state.

By studying the proteome and looking at what proteins are present and the quantity present, we can figure out, for example, if a patient has a particular disease. That is the first huge application.

Read Full Interview Here

			What Microorganisms Naturally Live in the Mouth? Over 700 bacterial species co-inhabit healthy human mouth. These species exist at diverse locations in the mouth.

			The Use of Microbes in Biofuel Production Combating climate change requires several approaches in multiple industries.

	Each person's gut has a unique viral 'fingerprint' Each person's gut virus composition is as unique as a fingerprint, according to the first study to assemble a comprehensive database of viral populations in the human digestive system.

	Free online course launched to provide better understanding of the human microbiome A new, free, online course is being launched to help you discover more about the microbiome and its links to health throughout our lives.

	New microgel drug delivery method could improve effectiveness of pancreatic islet transplants Pancreatic islet transplants, which revive insulin production to treat type 1 diabetes, only last an average of three years.